Radha Charan Dash

416 total citations
34 papers, 350 citations indexed

About

Radha Charan Dash is a scholar working on Molecular Biology, Organic Chemistry and Genetics. According to data from OpenAlex, Radha Charan Dash has authored 34 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 6 papers in Organic Chemistry and 6 papers in Genetics. Recurrent topics in Radha Charan Dash's work include DNA Repair Mechanisms (10 papers), Genomics and Chromatin Dynamics (6 papers) and Cancer therapeutics and mechanisms (5 papers). Radha Charan Dash is often cited by papers focused on DNA Repair Mechanisms (10 papers), Genomics and Chromatin Dynamics (6 papers) and Cancer therapeutics and mechanisms (5 papers). Radha Charan Dash collaborates with scholars based in United States, India and United Kingdom. Radha Charan Dash's co-authors include M. Kyle Hadden, Dmitry M. Korzhnev, Alessandro A. Rizzo, Kakasaheb Mahadik, Graham C. Walker, Nimrat Chatterjee, Anant Paradkar, Ravindra S. Dhumal, Sachin K. Korde and Mahmoud E. S. Soliman and has published in prestigious journals such as Biochemistry, Journal of Virology and Journal of Medicinal Chemistry.

In The Last Decade

Radha Charan Dash

32 papers receiving 348 citations

Peers

Radha Charan Dash

ONCOL

CTM

Jenifer Borgognoni United Kingdom

Renate Sekul Germany

Lisandra M. Gava Brazil

Florent Delhommel France

Natalie J. Tatum United Kingdom

Laura Neely United States

Stefan O. Ochiana United States

Beáta Flachner Hungary

Kuan Pern Tan Singapore

Özge Şensoy Türkiye

Jenifer Borgognoni United Kingdom

Radha Charan Dash

280 ×1.3

52 ×0.9

ONCOL

57 ×1.1

73 ×1.6

CTM

25 ×0.6

Citations per year, relative to Radha Charan Dash Radha Charan Dash (= 1×) peers Jenifer Borgognoni

Countries citing papers authored by Radha Charan Dash

Since Specialization

Citations

This map shows the geographic impact of Radha Charan Dash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Radha Charan Dash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Radha Charan Dash more than expected).

Fields of papers citing papers by Radha Charan Dash

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Radha Charan Dash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Radha Charan Dash. The network helps show where Radha Charan Dash may publish in the future.

Co-authorship network of co-authors of Radha Charan Dash

This figure shows the co-authorship network connecting the top 25 collaborators of Radha Charan Dash. A scholar is included among the top collaborators of Radha Charan Dash based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Radha Charan Dash. Radha Charan Dash is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dash, Radha Charan, S J James, Marcello Stanzione, et al.. (2024). Lead compound profiling for small molecule inhibitors of the REV1-CT/RIR Translesion synthesis Protein-Protein interaction. Bioorganic & Medicinal Chemistry. 106. 117755–117755. 3 indexed citations

Wen, Jiachen, et al.. (2023). 8-Hydroxyquinoline derivatives suppress GLI1-mediated transcription through multiple mechanisms. Bioorganic Chemistry. 132. 106387–106387. 2 indexed citations

Henriksen, Niel M., Radha Charan Dash, M. Kyle Hadden, et al.. (2023). Development of Enterovirus Antiviral Agents That Target the Viral 2C Protein. ChemMedChem. 18(10). e202200541–e202200541. 4 indexed citations

Dash, Radha Charan, et al.. (2021). Structure-based virtual screening identifies an 8-hydroxyquinoline as a small molecule GLI1 inhibitor. Molecular Therapy — Oncolytics. 20. 265–276. 12 indexed citations

Dash, Radha Charan & M. Kyle Hadden. (2021). Protein–Protein Interactions in Translesion Synthesis. Molecules. 26(18). 5544–5544. 9 indexed citations

Huang, Chang, Denzil Bernard, Radha Charan Dash, et al.. (2020). Small molecules block the interaction between porcine reproductive and respiratory syndrome virus and CD163 receptor and the infection of pig cells. Virology Journal. 17(1). 116–116. 37 indexed citations

Dash, Radha Charan, et al.. (2018). A metadynamic approach to understand the recognition mechanism of the histone H3 tail with the ATRXADD domain. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1861(6). 594–602. 4 indexed citations

Dash, Radha Charan, et al.. (2018). Small molecule scaffolds that disrupt the Rev1-CT/RIR protein-protein interaction. Bioorganic & Medicinal Chemistry. 26(14). 4301–4309. 11 indexed citations

Teske, Kelly A., et al.. (2018). Development of posaconazole-based analogues as hedgehog signaling pathway inhibitors. European Journal of Medicinal Chemistry. 163. 320–332. 12 indexed citations

10.

Dash, Radha Charan, et al.. (2018). Structural Approach To Identify a Lead Scaffold That Targets the Translesion Synthesis Polymerase Rev1. Journal of Chemical Information and Modeling. 58(11). 2266–2277. 18 indexed citations

11.

Dash, Radha Charan, et al.. (2017). Sequence and structure insights of kazal type thrombin inhibitor protein: Studied with phylogeny, homology modeling and dynamic MM/GBSA studies. International Journal of Biological Macromolecules. 108. 1045–1052. 11 indexed citations

12.

Rizzo, Alessandro A., Nimrat Chatterjee, Radha Charan Dash, et al.. (2017). Identification of Small Molecule Translesion Synthesis Inhibitors That Target the Rev1-CT/RIR Protein−Protein Interaction. ACS Chemical Biology. 12(7). 1903–1912. 46 indexed citations

13.

Dash, Radha Charan, et al.. (2016). A molecular dynamics approach to identify an oxysterol-based hedgehog pathway inhibitor. Biochimica et Biophysica Acta (BBA) - General Subjects. 1861(2). 168–177. 7 indexed citations

14.

Kanhed, Ashish M., et al.. (2015). Benzo[e]pyrimido[5,4-b][1,4]diazepin-6(11H)-one derivatives as Aurora A kinase inhibitors: LQTA-QSAR analysis and detailed systematic validation of the developed model. Molecular Diversity. 19(4). 965–974. 10 indexed citations

15.

Kanhed, Ashish M., et al.. (2014). Design, synthesis, pharmacological evaluation and computational studies of 1-(biphenyl-4-yl)-2-[4-(substituted phenyl)-piperazin-1-yl]ethanones as potential antipsychotics. European Journal of Medicinal Chemistry. 74. 358–365. 11 indexed citations

16.

Dash, Radha Charan, et al.. (2014). Identification of new novel scaffold for Aurora A inhibition by pharmacophore modeling and virtual screening. Molecular Diversity. 18(4). 853–863. 4 indexed citations

17.

Dash, Radha Charan, et al.. (2013). QSAR Study on Diketo Acid and Carboxamide Derivatives as Potent HIV- 1 Integrase Inhibitor. Letters in Drug Design & Discovery. 11(5). 618–627. 3 indexed citations

18.

Dash, Radha Charan, et al.. (2012). Design, Synthesis, Pharmacological Evaluation and Descriptor Based Similarities Study of N,N-diphenyl-2-[4-(substituted phenyl)piperazin-1- yl]acetamides as Potential Antipsychotics. Medicinal Chemistry. 8(6). 1069–1075. 2 indexed citations

19.

Dash, Radha Charan, et al.. (2011). Scaffold hopping for identification of novel D2 antagonist based on 3D pharmacophore modelling of illoperidone analogs. Molecular Diversity. 16(2). 367–375. 8 indexed citations

20.

Dash, Radha Charan, et al.. (2011). Exploration of new scaffolds as potential MAO-A inhibitors using pharmacophore and 3D-QSAR based in silico screening. Bioorganic & Medicinal Chemistry Letters. 21(8). 2419–2424. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact